![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ZymeQuest Exercises Option for Rights to Blood Platelet Technology
ZymeQuest Exercises Option for Rights to Blood Platelet Technology
ZymeQuest, a company that discovers, develops and commercializes carbohydrate-modified blood products for use in transfusion medicine, has exercised its option to license worldwide rights to a new method of treating platelets developed by Brigham and Women's Hospital. The new method, designed to enable platelets to be stored under refrigeration, could prolong their shelf life by a week or more.
PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=219305&categoryid=10)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct